26190974|t|Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
26190974|a|Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive weakness and muscle atrophy related to the loss of upper and lower motor neurons (MNs) without a curative treatment. There is experimental evidence suggesting that retinoids may be involved in ALS pathogenesis. Bexarotene (Bxt) is a retinoid-X receptor agonist used in the treatment of cutaneous lymphoma with a favorable safety profile whose effects have been recently investigated in other neurodegenerative diseases. In this study, we analyze the potential therapeutic effect of Bxt in the SOD1(G93A) mouse model of ALS. Mice were treated with Bxt or vehicle five times per week from day 60 onward. Survival, weight, and neuromuscular function studies together with histological and biochemical analyses were performed. Bxt significantly delayed motor function deterioration, ameliorated the loss of body weight, and extended mice survival up to 30% of the symptomatic period. Histological analyses of the lumbosacral spinal cord revealed that Bxt markedly delayed the early motor-neuron degeneration occurring at presymptomatic stages in ALS-transgenic mice. Bxt treatment contributed to preserve the MN homeostasis in the SOD1(G93A) mice. Particularly, it reduced the neuronal loss and the chromatolytic response, induced nucleolar hypertrophy, decreased the formation of ubiquitylated inclusions, and modulated the lysosomal response. As an agonist of the retinoic-X receptor (RXR) pathway, Bxt notably increased the nuclear expression of the RXRalpha throughout transcriptionally active euchromatin domains. Bxt also contributed to protect the MN environment by reducing reactive astrogliosis and preserving perisomatic synapsis. Overall, these neuroprotective effects suggest that treatment with Bxt could be useful in ALS, particularly in those cases related to SOD1 mutations. 
26190974	26	36	Bexarotene	Chemical	MESH:D000077610
26190974	44	48	SOD1	Gene	20655
26190974	49	53	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:10090;CA#:257327
26190974	55	60	Mouse	Species	10090
26190974	70	99	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
26190974	101	130	Amyotrophic lateral sclerosis	Disease	MESH:D000690
26190974	132	135	ALS	Disease	MESH:D000690
26190974	142	167	neurodegenerative disease	Disease	MESH:D019636
26190974	197	205	weakness	Disease	MESH:D018908
26190974	210	224	muscle atrophy	Disease	MESH:D009133
26190974	361	370	retinoids	Chemical	MESH:D012176
26190974	390	393	ALS	Disease	MESH:D000690
26190974	408	418	Bexarotene	Chemical	MESH:D000077610
26190974	420	423	Bxt	Chemical	MESH:D000077610
26190974	483	501	cutaneous lymphoma	Disease	MESH:D008223
26190974	589	615	neurodegenerative diseases	Disease	MESH:D019636
26190974	679	682	Bxt	Chemical	MESH:D000077610
26190974	690	694	SOD1	Gene	20655
26190974	695	699	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:10090;CA#:257327
26190974	701	706	mouse	Species	10090
26190974	716	719	ALS	Disease	MESH:D000690
26190974	721	725	Mice	Species	10090
26190974	744	747	Bxt	Chemical	MESH:D000077610
26190974	920	923	Bxt	Chemical	MESH:D000077610
26190974	946	974	motor function deterioration	Disease	MESH:D003291
26190974	1026	1030	mice	Species	10090
26190974	1144	1147	Bxt	Chemical	MESH:D000077610
26190974	1175	1200	motor-neuron degeneration	Disease	MESH:D009410
26190974	1239	1242	ALS	Disease	MESH:D000690
26190974	1254	1258	mice	Species	10090
26190974	1260	1263	Bxt	Chemical	MESH:D000077610
26190974	1302	1304	MN	Disease	
26190974	1324	1328	SOD1	Gene	20655
26190974	1329	1333	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:10090;CA#:257327
26190974	1335	1339	mice	Species	10090
26190974	1370	1383	neuronal loss	Disease	MESH:D009410
26190974	1434	1445	hypertrophy	Disease	MESH:D006984
26190974	1594	1597	Bxt	Chemical	MESH:D000077610
26190974	1646	1654	RXRalpha	Gene	20181
26190974	1712	1715	Bxt	Chemical	MESH:D000077610
26190974	1748	1750	MN	Disease	
26190974	1784	1796	astrogliosis	Disease	MESH:D005911
26190974	1901	1904	Bxt	Chemical	MESH:D000077610
26190974	1924	1927	ALS	Disease	MESH:D000690
26190974	1968	1972	SOD1	Gene	20655
26190974	Association	MESH:D000690	RS#:121912438;HGVS:p.G93A;CorrespondingGene:6647
26190974	Association	MESH:D000077610	RS#:121912438;HGVS:p.G93A;CorrespondingGene:6647
26190974	Negative_Correlation	MESH:D000077610	MESH:D003291
26190974	Negative_Correlation	MESH:D000077610	MESH:D008223
26190974	Positive_Correlation	MESH:D000077610	20181
26190974	Positive_Correlation	MESH:D000077610	MESH:D006984
26190974	Negative_Correlation	MESH:D000077610	MESH:D000690
26190974	Association	MESH:D000690	20655
26190974	Association	MESH:D012176	MESH:D000690
26190974	Negative_Correlation	MESH:D000077610	MESH:D005911
26190974	Negative_Correlation	MESH:D000077610	MESH:D009410
26190974	Association	MESH:D000690	6647

